Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Andeweg, Stijn Pde Gier, Brechje
Eggink, Dirk
van den Ende, Caroline
van Maarseveen, Noortje
Ali, Lubna
Vlaemynck, Boris
Schepers, Raf
Hahné, Susan J M
Reusken, Chantal B E M
de Melker, Hester E
van den Hof, Susan
Knol, Mirjam J
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections.Published in
Nature communications 2022;13(1):4738PMID
35961956ae974a485f413a2113503eed53cd6c53
10.1038/s41467-022-31838-8
Scopus Count
Collections
Related articles
- Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
- Authors: Powell AA, Kirsebom F, Stowe J, Ramsay ME, Lopez-Bernal J, Andrews N, Ladhani SN
- Issue date: 2023 Apr
- Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
- Authors: Tsang NNY, So HC, Cowling BJ, Leung GM, Ip DKM
- Issue date: 2023 Apr
- Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
- Authors: Tamandjou Tchuem CR, Auvigne V, Vaux S, Montagnat C, Paireau J, Monnier Besnard S, Gabet A, Benhajkassen N, Le Strat Y, Parent Du Chatelet I, Levy-Bruhl D
- Issue date: 2023 Mar 24
- Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
- Authors: Tan CY, Chiew CJ, Pang D, Lee VJ, Ong B, Lye DC, Tan KB
- Issue date: 2023 Jul
- A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
- Authors: He X, Su J, Ma Y, Zhang W, Tang S
- Issue date: 2022